Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonya VanPatten

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Physiological Reports|January 1, 2017
Effects of novel muscarinic M3 receptor ligand C1213 in pulmonary arterial hypertension modelsMohamed Ahmed, Sonya VanPatten, Satyan Lakshminrusimha, et al.
Future Medicinal Chemistry|July 17, 2020
Evidence supporting the use of peptides and peptidomimetics as potential SARS-CoV-2 (COVID-19) therapeuticsSonya VanPatten, Mingzhu He, Ahmad Altiti, et al.
Archiv Der Pharmazie|November 19, 2013
Novel arylazoarylmethane as potential inhibitor of macrophage migration inhibitory factorMingzhu He, Christine Metz, Kai Fan Cheng, et al.
European Journal of Pharmacology|June 27, 2014
Novel inhibitors of macrophage migration inhibitory factor prevent cytokine-induced beta cell deathMilica Vujicic, Ivana Nikolic, Tamara Krajnovic, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Protease-Resistant Azapeptide GLP-1 Analogue Improves Metabolic Control in Diet-Induced ObesityMingzhu He, Kai Fan Cheng, Sonya VanPatten, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 4, 2011
Thyroxine is a potential endogenous antagonist of macrophage migration inhibitory factor (MIF) activityYousef Al-Abed, Christine N Metz, Kai Fan Cheng, et al.
Journal of Medicinal Chemistry|September 8, 2016
Amending HIV Drugs: A Novel Small-Molecule Approach To Target Lupus Anti-DNA AntibodiesSonya VanPatten, Shan Sun, Mingzhu He, et al.
Cells|June 10, 2023
Multi-Drug Cocktail Therapy Improves Survival and Neurological Function after Asphyxial Cardiac Arrest in RodentsRishabh C Choudhary, Muhammad Shoaib, Kei Hayashida, et al.
Nature Communications|November 28, 2022
Thiocarbazate building blocks enable the construction of azapeptides for rapid development of therapeutic candidatesAhmad Altiti, Mingzhu He, Sonya VanPatten, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Physiological Reports|January 1, 2017
Effects of novel muscarinic M3 receptor ligand C1213 in pulmonary arterial hypertension modelsMohamed Ahmed, Sonya VanPatten, Satyan Lakshminrusimha, et al.
Future Medicinal Chemistry|July 17, 2020
Evidence supporting the use of peptides and peptidomimetics as potential SARS-CoV-2 (COVID-19) therapeuticsSonya VanPatten, Mingzhu He, Ahmad Altiti, et al.
Archiv Der Pharmazie|November 19, 2013
Novel arylazoarylmethane as potential inhibitor of macrophage migration inhibitory factorMingzhu He, Christine Metz, Kai Fan Cheng, et al.
European Journal of Pharmacology|June 27, 2014
Novel inhibitors of macrophage migration inhibitory factor prevent cytokine-induced beta cell deathMilica Vujicic, Ivana Nikolic, Tamara Krajnovic, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Protease-Resistant Azapeptide GLP-1 Analogue Improves Metabolic Control in Diet-Induced ObesityMingzhu He, Kai Fan Cheng, Sonya VanPatten, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 4, 2011
Thyroxine is a potential endogenous antagonist of macrophage migration inhibitory factor (MIF) activityYousef Al-Abed, Christine N Metz, Kai Fan Cheng, et al.
Journal of Medicinal Chemistry|September 8, 2016
Amending HIV Drugs: A Novel Small-Molecule Approach To Target Lupus Anti-DNA AntibodiesSonya VanPatten, Shan Sun, Mingzhu He, et al.
Cells|June 10, 2023
Multi-Drug Cocktail Therapy Improves Survival and Neurological Function after Asphyxial Cardiac Arrest in RodentsRishabh C Choudhary, Muhammad Shoaib, Kei Hayashida, et al.
Nature Communications|November 28, 2022
Thiocarbazate building blocks enable the construction of azapeptides for rapid development of therapeutic candidatesAhmad Altiti, Mingzhu He, Sonya VanPatten, et al.
Pageof 2